Applied Genetic Technologies Corporation (AGTC) Financial Statements (2024 and earlier)

Company Profile

Business Address 14193 NW 119TH TERRACE
ALACHUA, FL 32615
State of Incorp. DE
Fiscal Year End June 30
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2022
MRQ
6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including: 46,366107,10080,50082,000104,905126,700
Cash and cash equivalents 46,366105,05238,46326,70331,06530,706
Short-term investments  2,00041,99555,29273,84095,994
Other undisclosed cash, cash equivalents, and short-term investments  48425  
Receivables    13210174
Other undisclosed current assets 3,1952,6072,4642,2714,0093,361
Total current assets: 49,561109,70782,96484,284109,124130,235
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization  3480
Operating lease, right-of-use asset 3,0433,1673,422
Property, plant and equipment 4,7144,6584,3114,4305,2542,661
Long-term investments and receivables 7,8078,0008,096 1,98011,749
Long-term investments 7,8078,0008,096 1,98011,749
Intangible assets, net (including goodwill) 1,4331,2871,0981,0139681,219
Intangible assets, net (excluding goodwill) 1,4331,2871,0981,0139681,219
Other noncurrent assets 1261133485441,20659
Other undisclosed noncurrent assets    1,945 2,000
Total noncurrent assets: 17,12317,25917,3557,9329,40817,688
TOTAL ASSETS: 66,684126,966100,31992,216118,532147,923
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 9,8094,7694,6533,7373,1314,292
Taxes payable     1,514
Employee-related liabilities3,4492,8903,2982,4062,1861,780
Accounts payable 2,9111,8791,3551,331945998
Accrued liabilities 3,449     
Debt 9,2982,21948   
Deferred revenue and credits6,29520,996
Other undisclosed current liabilities 6,10012,7268,2625,6184,9692,868
Total current liabilities: 25,20719,71412,9639,35514,39528,156
Noncurrent Liabilities
Long-term debt and lease obligation 2,7803,4184,108   
Finance lease, liability   38
Liabilities, other than long-term debt 982992,5554,1524,9554,438
Deferred revenue and credits6104,438
Other liabilities 982992,5554,1524,345 
Operating lease, liability 2,7803,4184,070
Other undisclosed noncurrent liabilities 9,12217,7279,677   
Total noncurrent liabilities: 12,00021,44416,3404,1524,9554,438
Total liabilities: 37,20741,15829,30313,50719,35032,594
Equity
Equity, attributable to parent 29,47785,80871,01678,70999,182115,329
Common stock 514325181818
Treasury stock, value (256)(211)(88)(85)(49) 
Additional paid in capital 337,894325,245252,519214,324210,139204,937
Accumulated deficit (308,212)(239,269)(181,440)(135,548)(110,926)(89,626)
Total equity: 29,47785,80871,01678,70999,182115,329
TOTAL LIABILITIES AND EQUITY: 66,684126,966100,31992,216118,532147,923

Income Statement (P&L) ($ in thousands)

9/30/2022
TTM
6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
Revenues 3255002,45341,69224,18639,473
Gross profit: 3255002,45341,69224,18639,473
Operating expenses (66,500)(58,951)(49,395)(46,042)(46,570)(37,571)
Operating income (loss): (66,175)(58,451)(46,942)(4,350)(22,384)1,902
Nonoperating income (expense) (2,575)(1,390)1,1802,4551,176905
Investment income, nonoperating 991161,1852,0091,301952
Other nonoperating income (expense)   (5)446(125)(47)
Interest and debt expense (2,674)(1,506)(8)   
Other undisclosed income from continuing operations before equity method investments, income taxes 2,6741,5068   
Income (loss) from continuing operations before equity method investments, income taxes: (68,750)(59,841)(45,762)(1,895)(21,208)2,807
Loss from equity method investments (193)(96)(47)(35)  
Income (loss) from continuing operations before income taxes: (68,943)(59,937)(45,809)(1,930)(21,208)2,807
Income tax expense (benefit)  2,108(83)(76)(72)(2,400)
Income (loss) from continuing operations: (68,943)(57,829)(45,892)(2,006)(21,280)407
Income (loss) before gain (loss) on sale of properties:(68,943)(57,829)(45,892)(2,006)(21,280)407
Other undisclosed net loss     (20) 
Net income (loss) available to common stockholders, diluted: (68,943)(57,829)(45,892)(2,006)(21,300)407

Comprehensive Income ($ in thousands)

9/30/2022
TTM
6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
Net income (loss): (68,943)(57,829)(45,892)(2,006)(21,300)407
Comprehensive income (loss), net of tax, attributable to parent: (68,943)(57,829)(45,892)(2,006)(21,300)407

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: